BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, Ochi H, Kira J. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One 2014;9:e95367. [PMID: 24736746 DOI: 10.1371/journal.pone.0095367] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Ranjbar R, Karampoor S, Jalilian FA. The protective effect of Helicobacter Pylori infection on the susceptibility of multiple sclerosis. Journal of Neuroimmunology 2019;337:577069. [DOI: 10.1016/j.jneuroim.2019.577069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
2 Efthymiou G, Liaskos C, Simopoulou T, Marou E, Patrikiou E, Scheper T, Meyer W, Daoussis D, Sakkas LI, Bogdanos DP. Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis. Immunol Res 2020;68:39-47. [PMID: 32253703 DOI: 10.1007/s12026-020-09124-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Okuno T, Nakatsuji Y, Kinoshita M, Takata K, Koda T, Yamashita K, Nanba A, Mochizuki H. The role of gut microbiota and diet in experimental autoimmune encephalitis and multiple sclerosis. Clin Exp Neuroimmunol 2015;6:30-7. [DOI: 10.1111/cen3.12270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation. Acta Neurol Scand 2017;136:606-16. [PMID: 28542724 DOI: 10.1111/ane.12775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
5 Robinson K, Stephens J, Constantinescu CS, Gran B. Helicobacter pylori, Experimental Autoimmune Encephalomyelitis, and Multiple Sclerosis. In: Constantinescu C, Arsenescu R, Arsenescu V, editors. Neuro-Immuno-Gastroenterology. Cham: Springer International Publishing; 2016. pp. 97-122. [DOI: 10.1007/978-3-319-28609-9_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Bonnan M. Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments. Mult Scler Int 2015;2015:296184. [PMID: 25653878 DOI: 10.1155/2015/296184] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ochi H, Fujihara K. Demyelinating diseases in Asia. Curr Opin Neurol 2016;29:222-8. [PMID: 27070217 DOI: 10.1097/WCO.0000000000000328] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
8 Axisa PP, Hafler DA. Multiple sclerosis: genetics, biomarkers, treatments. Curr Opin Neurol 2016;29:345-53. [PMID: 27058221 DOI: 10.1097/WCO.0000000000000319] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 14.3] [Reference Citation Analysis]
9 Kinoshita M, Daifu M, Tanaka K, Tanaka M. Prognostic value of oligoclonal IgG bands in Japanese clinically isolated syndrome converting to clinically definite multiple sclerosis. Journal of Neuroimmunology 2017;307:1-6. [DOI: 10.1016/j.jneuroim.2017.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Kira J, Isobe N. Helicobacter pylori infection and demyelinating disease of the central nervous system. Journal of Neuroimmunology 2019;329:14-9. [DOI: 10.1016/j.jneuroim.2018.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
11 Azumagawa K, Nakashima I, Kaneko K, Torisu H, Sakai Y, Kira R, Sakuma H, Tanaka K, Shigeri Y, Tanaka Y, Nakajima H, Shimakawa S, Tamai H. A nation-wide survey of Japanese pediatric MOG antibody-associated diseases. Brain Dev 2021;43:705-13. [PMID: 33610339 DOI: 10.1016/j.braindev.2021.01.008] [Reference Citation Analysis]
12 Cook KW, Crooks J, Hussain K, O'Brien K, Braitch M, Kareem H, Constantinescu CS, Robinson K, Gran B. Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front Microbiol. 2015;6:52. [PMID: 25762984 DOI: 10.3389/fmicb.2015.00052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
13 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yao G, Wang P, Luo XD, Yu TM, Harris RA, Zhang XM. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neurosci Lett. 2016;620:1-7. [PMID: 27033666 DOI: 10.1016/j.neulet.2016.03.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
15 Hayashi F, Isobe N, Glanville J, Matsushita T, Maimaitijiang G, Fukumoto S, Watanabe M, Masaki K, Kira JI. A new clustering method identifies multiple sclerosis-specific T-cell receptors. Ann Clin Transl Neurol 2021;8:163-76. [PMID: 33400858 DOI: 10.1002/acn3.51264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Cavallo S. Immune-mediated genesis of multiple sclerosis. J Transl Autoimmun 2020;3:100039. [PMID: 32743522 DOI: 10.1016/j.jtauto.2020.100039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Tsunoda I, Sato F, Omura S, Fujita M, Sakiyama N, Park AM. Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis. Clin Exp Neuroimmunol 2016;7:330-45. [PMID: 28603559 DOI: 10.1111/cen3.12341] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
18 Robinson K. Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies. Diseases. 2015;3:34-55. [PMID: 28943607 DOI: 10.3390/diseases3020034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
19 Cossu D, Yokoyama K, Tomizawa Y, Momotani E, Hattori N. Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system. Sci Rep 2017;7:3179. [PMID: 28600575 DOI: 10.1038/s41598-017-03370-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
20 Housley WJ, Pitt D, Hafler DA. Biomarkers in multiple sclerosis. Clinical Immunology 2015;161:51-8. [DOI: 10.1016/j.clim.2015.06.015] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 15.3] [Reference Citation Analysis]
21 Azumagawa K, Nomura S, Shigeri Y, Jones LS, Sato DK, Nakashima I, Kashiwagi M, Tanabe T, Shimakawa S, Nakajima H, Tamai H. Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy. Brain and Development 2016;38:690-3. [DOI: 10.1016/j.braindev.2016.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
22 Dias-Carneiro RP, von Glehn F, Moraes AS, Boldrini VO, Damasceno A, Andrade MD, Lima AC, Casanova CS, Tilbery CP, Damasceno BP, Santos LM, Brandão CO. MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients. J Neuroimmunol 2016;300:30-5. [PMID: 27806873 DOI: 10.1016/j.jneuroim.2016.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
23 Sadeghmousavi S, Rezaei N. COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment. SN Compr Clin Med 2020;:1-6. [PMID: 32895640 DOI: 10.1007/s42399-020-00504-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
24 Niino M, Sato S, Fukazawa T, Yoshimura S, Hisahara S, Matsushita T, Isobe N, Yoshida K, Houzen H, Miyazaki Y, Shimohama S, Kikuchi S, Kira J. Latitude and HLA-DRB1 alleles independently affect the emergence of cerebrospinal fluid IgG abnormality in multiple sclerosis. Mult Scler 2015;21:1112-20. [PMID: 25583844 DOI: 10.1177/1352458514560924] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kim SH, Kim HJ. Central nervous system neuroinflammatory disorders in Asian/Pacific regions. Curr Opin Neurol 2016;29:372-80. [PMID: 27128108 DOI: 10.1097/WCO.0000000000000315] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
26 Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B, Biberacher V, van Pesch V, Sindic C, Bang Oturai A, Søndergaard HB, Sellebjerg F, Jensen PE, Comabella M, Montalban X, Pérez-Boza J, Malhotra S, Lechner-Scott J, Broadley S, Slee M, Taylor B, Kermode AG, Gourraud PA, Sawcer SJ, Andreassen BK, Dubois B, Harbo HF; International Multiple Sclerosis Genetics Consortium. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain 2015;138:632-43. [PMID: 25616667 DOI: 10.1093/brain/awu405] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]